Evolent Health (EVH) Debt/EBITDA US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
Debt/EBITDA | -4.09 | 0.82 | 0.16 | 39.1 | 9.74 | 5.29 | |||
Changes by years, y/y, % | -564% | -120% | -81% | +24 795% | -75% | +61.7% |
Evolent Health. Debt/EBITDA
Evolent Health. Debt/EBITDA, changes, %
Evolent Health (EVH) Debt/EBITDA US GAAP (quarter values) |
||||||||
2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
Debt/EBITDA | -15.6 | 26.2 | 9.74 | 5.10 | 5.29 | 5.29 | ||
Changes by years, y/y, % | -671% | +100% | -75% | -153% | -134% | |||
Changes by quarters, q/q, % | +62% | -268% | -63% | -48% | +4% |